Antibiotic resistance has always been a global public health problem. While many of my colleagues carry out research aimed at discovering new antibiotics, my job is to help all of us get better at looking after the antibiotics we already have.
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...
Patients, partnerships and pioneering science are at the heart of developing advanced therapies in the next wave of innovation to provide transformative treatments and cures, according to latest developments reported at the Better Science, Better Health: Advanced Therapies – Opportunities and...
Collaboration with the Royal Society for Public Health and ITN Productions: the role of vaccines in helping combat antimicrobial resistance (AMR).
Thanks to the Welsh Government’s £80 million New Treatment Fund, patients are benefiting from collaborative efforts to improve access to the very latest medicines, no matter where they live or what their disease.
The Association of the British Pharmaceutical Industry (ABPI) has responded to the consultation by the National Institute for Health and Care Excellence (NICE) and NHS England on evaluating and funding drugs and other health technologies.
New film and online resources showcase the milestones, achievements and future of the pharmaceutical sector in the UK.
The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new report launched today [6 March].
On January 17, Health Ministers from OECD countries will gather in Paris to discuss how healthcare systems can reform to better deal with the challenges and to realize the opportunities of tomorrow. Important milestones are on the agenda including how to tackle ineffective spending in healthcare and...
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member, effective Thursday 20 July 2017.
The Department of Health has today [27 October] published the Q2 2017 PPRS data showing that the pharmaceutical industry has paid a total of £190 million during the first two quarters of 2017 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).